#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14658	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2325	763.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1573	1573	C	894	C,T	892,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25188	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4061	772.3	0	.	n	.	0	T695C	SNP	695	695	T	1336	1336	C	949	C,T,G,A	944,2,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25188	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4061	772.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1978	1978	A	1046	A,G	1044,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25188	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4061	772.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2612	2612	C	914	C,T	913,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25188	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4061	772.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2686	2686	A	894	A,G	892,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25188	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4061	772.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3238	3238	C	846	C,T,A	844,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2176	folP	855	855	100.0	folP.l15.c4.ctg.1	2174	124.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1367	1369	AGC	194;195;194	A;G,A;C	194;194,1;194	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5106	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3878	164.0	1	SNP	p	S91F	1	.	.	271	273	TTC	795	797	TTC	190;192;190	T;T;C	190;192;190	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5106	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3878	164.0	1	SNP	p	G95N	0	.	.	283	285	GGC	807	809	GGC	202;202;201	G;G,C;C	202;201,1;201	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5106	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3878	164.0	1	SNP	p	D95G	1	.	.	283	285	GGC	807	809	GGC	202;202;201	G;G,C;C	202;201,1;201	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1942	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1859	130.3	1	SNP	p	G45D	0	.	.	133	135	GGC	829	831	GGC	203;201;205	G;G;C	203;201;205	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1020	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1565	81.2	0	.	n	.	0	A197.	DEL	197	197	A	862	862	A	203	A	203	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4786	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3436	173.4	1	SNP	p	D86N	0	.	.	256	258	GAC	781	783	GAC	203;201;201	G;A,T,C;C,G	203;199,1,1;199,2	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4786	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3436	173.4	1	SNP	p	R87I	0	.	.	259	261	CGT	784	786	CGT	197;198;198	C,T;G;T	196,1;198;198	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4786	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3436	173.4	1	SNP	p	S87R	1	.	.	259	261	CGT	784	786	CGT	197;198;198	C,T;G;T	196,1;198;198	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4786	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3436	173.4	1	SNP	p	R87W	0	.	.	259	261	CGT	784	786	CGT	197;198;198	C,T;G;T	196,1;198;198	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4786	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3436	173.4	1	SNP	p	S88P	0	.	.	262	264	TCC	787	789	TCC	200;204;202	T;C;C	200;204;202	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4170	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3287	158.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1931	1933	GGC	240;239;239	G;G,T;C,A	240;238,1;238,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4072	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2841	178.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1449	1451	GCA	256;256;257	G;C;A,C	256;256;256,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4072	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2841	178.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1452	1454	ATC	262;259;259	A,C;T,C,G;C	261,1;257,1,1;259	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4072	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2841	178.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1464	1466	GTG	269;267;269	G;T,G;G	269;266,1;269	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4072	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2841	178.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1464	1466	GTG	269;267;269	G;T,G;G	269;266,1;269	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4072	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2841	178.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1968	1970	ACC	224;223;222	A;C;C	224;223;222	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4072	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2841	178.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2022	2024	GCG	216;217;216	G;C,G;G,A,T	216;216,1;214,1,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4072	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2841	178.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2022	2024	GCG	216;217;216	G;C,G;G,A,T	216;216,1;214,1,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4072	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2841	178.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2145	2147	AGC	207;207;210	A;G;C	206;206;209	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4072	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2841	178.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2154	2156	GGC	209;211;212	G,A;G;C	208,1;211;212	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4072	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2841	178.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2172	2174	CCG	201;202;202	C,T;C;G	200,1;202;202	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5380	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3619	185.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1905	1907	CCG	212;213;214	C;C;G	212;213;214	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2400	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2503	119.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	869	869	C	173	C	173	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	230	porB1a	984	161	93.79	porB1a.l15.c30.ctg.1	164	43.4	0	.	p	.	0	S271T	NONSYN	811	813	TCG	62	64	ACT	57;57;57	A;C,T;T	57;56,1;57	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	230	porB1a	984	161	93.79	porB1a.l15.c30.ctg.1	164	43.4	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	68	70	GAT	57;57;57	G;A;T	57;57;57	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	230	porB1a	984	161	93.79	porB1a.l15.c30.ctg.1	164	43.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	71	73	AGT	57;57;57	A;G,T;T	57;56,1;57	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	230	porB1a	984	161	93.79	porB1a.l15.c30.ctg.1	164	43.4	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	80	82	TAC	57;57;57	T;A;C	57;57;57	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	E48G	NONSYN	142	144	GAA	660	662	GGA	216;216;215	G;G;A	216;216;215	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	V75I	NONSYN	223	225	GTT	741	743	ATT	225;223;222	A,G;T;T,A	223,2;223;221,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	783	785	AGC	233;235;234	A;G,A;C	233;234,1;234	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	V98I	NONSYN	292	294	GTC	810	812	ATC	215;211;210	A;T;C,T	215;211;209,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	875	876	CG	167;166	C;G	167;166	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	878	880	CAG	171;172;172	C;A;G	171;172;172	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	882	884	AAA	164;164;165	A;A;A,G	164;164;164,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	909	911	TAT	159;162;163	T,A;A;T,C,A	158,1;162;161,1,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	N134E	NONSYN	400	402	AAT	918	920	GAG	170;171;172	G,T;A;G	169,1;171;172	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	V135L	NONSYN	403	405	GTG	921	923	CTT	170;172;172	C;T;T	170;172;172	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	G140K	NONSYN	418	420	GGA	936	938	AAA	182;183;184	A,G;A;A,G	181,1;183;183,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	945	947	GAA	190;189;190	G;A;A	190;189;189	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	969	971	GCA	187;189;188	G;C;A	187;189;188	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1155	1157	TCA	231;229;230	T,G;C,A;A	230,1;228,1;230	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1275	1277	CAA	167;169;170	C;A;A	167;169;170	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	.	INDELS	760	762	ACA	1279	1283	ATCAA	166;160;157;154;155	A;T,G;C;A;A,G	166;159,1;157;154;154,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	.	INDELS	763	764	TG	1286	1288	AGT	153;154;152	A;G;T	153;154;152	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1293	1295	GAT	154;153;158	G;A;T	154;153;158	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	T269S	NONSYN	805	807	ACC	1329	1331	AGC	171;173;174	A;G;C	171;173;174	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1401	1403	AGT	192;193;194	A;G,T;T	192;192,1;194	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1407	1409	GAC	200;202;207	G;A;C,G	200;202;206,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1410	1412	TAC	208;209;214	T;A;C	208;209;214	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	1	SNP	p	G120K	1	.	.	358	360	AAG	875	877	CGG	167;166;168	C;G;G	167;166;168	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	1	SNP	p	D121N	0	.	.	361	363	GAC	878	881	CGC	171;172;171	C;G;C,G	171;172;170,1	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2412	porB1b	1041	1041	96.37	porB1b.l6.c4.ctg.1	1910	156.0	1	SNP	p	A121D	1	.	.	361	363	GAC	878	881	CGC	171;172;171	C;G;C,G	171;172;170,1	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	186	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	43.4	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	57;57;57	A;C,T;T	57;56,1;57	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	186	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	43.4	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	57;57;57	A;G,T;T	57;56,1;57	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	186	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	43.4	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	57;57;57	G;A;C	57;57;57	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	186	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	43.4	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	57;57;57	T;A;C	57;57;57	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9616	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5368	223.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1476	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1627	113.0	1	SNP	p	V57M	1	.	.	169	171	ATG	835	837	ATG	248;246;243	A;T;G	248;246;243	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
